Catalyst Wire Dossier Catalyst Wire Dossier

Unasyn-S

ampicillin-sulbactam · Pfizer
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Unasyn-S, covering 2012-05-18 to 2017-04-26. Get the full timeline:

Most recent: Clinical Trial Update: Special Use-Result Surveillance of Unasyn-S (Kit) for Intravenous Use - A Surveillance on High-dose (>6 g Daily) Administration -

See pricing